Smurf control in bone cells

Journal of Cellular Biochemistry

Volumn 110, Issue 3, 2010, Pages 554-563

  Xing, Lianping ^a,b   Zhang, Ming ^a,b   Chen, Di ^a,b  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Osteoblast; Proteasome degradation; Smurf; Ubiquitination

Indexed keywords

ANTINEOPLASTIC AGENT; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; BORTEZOMIB; EPOXOMICIN; RAP1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SMAD1 PROTEIN; SMURF1 PROTEIN; TRANSCRIPTION FACTOR RUNX2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BONE CELL; CARBOXY TERMINAL SEQUENCE; CARTILAGE CELL; CATALYSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; HUMAN; MESENCHYMAL STEM CELL; MOLECULARLY TARGETED THERAPY; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; UBIQUITINATION;

ANIMALS; BONE AND BONES; HUMANS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 77952714029     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22586     Document Type: Review

References (84)

1. Ballock RT, Heydemann A, Wakefield LM, Flanders KC, Roberts AB, Sporn MB. 1993. TGF-beta 1 prevents hypertrophy of epiphyseal chondrocytes: regulation of gene expression for cartilage matrix proteins and metalloproteases. Dev Biol 158(2):414-429.
2. Bassuk AG, Wallace RH, Buhr A, Buller AR, Afawi Z, Shimojo M, Miyata S, Chen S, Gonzalez-Alegre P, Griesbach HL, Wu S, Nashelsky M, Vladar EK, Antic D, Ferguson PJ, Cirak S, Voit T, Scott MP, Axelrod JD, Gurnett C, Daoud AS, Kivity S, Neufeld MY, Mazarib A, Straussberg R, Walid S, Korczyn AD, Slusarski DC, Berkovic SF, El-Shanti HI. 2008. A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome. Am J Hum Genet 83(5):572-581.
3. Bernassola F, Karin M, Ciechanover A, Melino G. 2008. The HECT family of E3 ubiquitin ligases: multiple players in cancer development Cancer Cell 14(1):10-21.
4. Bonni S, Wang HR, Causing CG, Kavsak P, Stroschein SL, Luo K, Wrana JL. 2001. TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol 3(6):587-595.
5. Chen C, Sun X, Guo P, Dong XY, Sethi P, Cheng X, Zhou J, Ling J, Simons JW, Lingrel JB, Dong JT. 2005. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells. J Biol Chem 280(50):41553-41561.
6. Ciechanover A. 1998. The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J 17(24):7151-7160.
7. Darnay BG, Besse A, Poblenz AT, Lamothe B, Jacoby JJ. 2007. TRAFs in RANK signaling. Adv Exp Med Biol 597:152-159.
8. Deng L, Wang C, Spencer E, Yang L, Braun A, You J, Slaughter C, Pickart C, Chen ZJ. 2000. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103(2):351-361.
9. Ditzel M, Wilson R, Tenev T, Zachariou A, Paul A, Deas E, Meier P. 2003. Degradation of DIAP1 by the N-end rule pathway is essential for regulating apoptosis. Nat Cell Biol 5(5):467-473.
10. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K., 2001. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276 16 12477-12480.
11. Friedenstein AJ, Chailakhjan RK, Lalykina KS. 1970. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3(4):393-403.
12. Fukunaga E, Inoue Y, Komiya S, Horiguchi K, Goto K, Saitoh M, Miyazawa K, Koinuma D, Hanyu A, Imamura T. 2008. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells. J Biol Chem 283(51):35660-35667.
13. Gao M, Karin M. 2005. Regulating the regulators: control of protein ubiquitination and ubiquitin-like modifications by extracellular stimuli. Mol Cell 19(5):581-593.
14. Gao M, Labuda T, Xia Y, Gallagher E, Fang D, Liu YC, Karin M. 2004. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 306(5694):271-275.
15. Gao S, Alarcon C, Sapkota G, Rahman S, Chen PY, Goerner N, Macias MJ, Erdjument-Bromage H, Tempst P, Massague J. 2009. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Mol Cell 36(3):457-468.
16. Garrett IR, Chen D, Gutierrez G, Zhao M, Escobedo A, Rossini G, Harris SE, Gallwitz W, Kim KB, Hu S, Crews CM, Mundy GR. 2003. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Invest 111(11):1771-1782.
17. Guo R, Yamashita M, Zhang Q, Zhou Q, Chen D, Reynolds DG, Awad HA, Yanoso L, Zhao L, Schwarz EM, Zhang YE, Boyce BF, Xing L. 2008. Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins. J Biol Chem 283(34):23084-23092.
18. Hayami R, Sato K, Wu W, Nishikawa T, Hiroi J, Ohtani-Kaneko R, Fukuda M, Ohta T. 2005. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2. Cancer Res 65(1):6-10.
19. Heissmeyer V, Rao A. 2008. Itching to end NF-kappaB. Nat Immunol 9(3):227-229.
20. Herman-Bachinsky Y, Ryoo HD, Ciechanover A, Gonen H. 2007. Regulation of the Drosophila ubiquitin ligase DIAP1 is mediated via several distinct ubiquitin system pathways. Cell Death Differ 14(4):861-871.
21. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu Rev Biochem 67:425-479.
22. Horiki M, Imamura T, Okamoto M, Hayashi M, Murai J, Myoui A, Ochi T, Miyazono K, Yoshikawa H, Tsumaki N. 2004. Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia. J Cell Biol 165(3):433-445.
23. Huang K, Johnson KD, Petcherski AG, Vandergon T, Mosser EA, Copeland NG, Jenkins NA, Kimble J, Bresnick EH. 2000. A HECT domain ubiquitin ligase closely related to the mammalian protein WWP1 is essential for Caenorhabditis elegans embryogenesis. Gene 252(1-2):137-145.
24. Huang C, Rajfur Z, Yousefi N, Chen Z, Jacobson K, Ginsberg MH. 2009. Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration. Nat Cell Biol 11(5):624-630.
25. Jian D, Ghali O, Lencel P, Broux O, Chauveau C, Devedjian JC, Hardouin P, Magne D. 2009. TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells. Life Sci. 84(15-16):499-504.
26. Jin YH, Jeon EJ, Li QL, Lee YH, Choi JK, Kim WJ, Lee KY, Bae SC. 2004. Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. J Biol Chem 279(28):29409-29417.
27. Jonason JH, Xiao G, Zhang M, Xing L, Chen D. 2009. Post-translational Regulation of Runx2 in Bone and Cartilage. J Dent Res 88(8):693-703.
28. Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I, Morony S, Rubin E, Sarao R, Hojilla CV, Komnenovic V, Kong YY, Schreiber M, Dixon SJ, Sims SM, Khokha R, Wada T, Penninger JM. 2006. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440(7084):692-696.
29. Jones DC, Wein MN, Glimcher LH. 2007. Schnurri-3: a key regulator of postnatal skeletal remodeling. Adv Exp Med Biol 602:1-13.
30. Kalkan T, Iwasaki Y, Park CY, Thomsen GH. 2009. Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-beta signaling that affects neural crest formation. Mol Biol Cell 20(14):3436-3450.
31. Kaneki H, Guo R, Chen D, Yao Z, Schwarz EM, Zhang YE, Boyce BF, Xing L. 2006. Tumor necrosis factor promotes Runx2 degradation through upregulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem 281(7):4326-4333.
32. Kasanov J, Pirozzi G, Uveges AJ, Kay BK. 2001. Characterizing Class I WW domains defines key specificity determinants and generates mutant domains with novel specificities. Chem Biol 8(3):231-241.
33. Kastrinaki MC, Sidiropoulos P, Roche S, Ringe J, Lehmann S, Kritikos H, Vlahava VM, Delorme B, Eliopoulos GD, Jorgensen C, Charbord P, Haupl T, Boumpas DT, Papadaki HA. 2008. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann Rheum Dis 67(6):741-749.
34. Kolf CM, Cho E, Tuan RS. 2007. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 9(1):204.
35. Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K, Miyazawa K. 2004. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1). Oncogene 23(41):6914-6923.
36. Kramer ER, Scheuringer N, Podtelejnikov AV, Mann M, Peters JM. 2000. Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol Biol Cell 11(5):1555-1569.
37. Kretzschmar M, Doody J, Massague J. 1997. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 389(6651):618-622.
38. Lamothe B, Webster WK, Gopinathan A, Besse A, Campos AD, Darnay BG. 2007. TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation. Biochem Biophys Res Commun 359(4):1044-1049.
39. Leonard CM, Fuld HM, Frenz DA, Downie SA, Massagué J, Newman SA. 1991. Role of transforming growth factor-beta in chondrogenic pattern formation in the embryonic limb: stimulation of mesenchymal condensation and fibronectin gene expression by exogenenous TGF-beta and evidence for endogenous TGF-beta-like activity. Dev Biol 145(1):99-109.
40. Li S, Lu K, Wang J, An L, Yang G, Chen H, Cui Y, Yin X, Xie P, Xing G, He F, Zhang L. 2009. Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation. Mol Cell Biochem [Epub ahead of print].
41. Lin X, Liang M, Feng X. 2000. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J Biol Chem 275:36818-36822. (Pubitemid 32002092)
42. Lu K, Yin X, Weng T, Xi S, Li L, Xing G, Cheng X, Yang X, Zhang L, He F. 2008. Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1. Nat Cell Biol 10(8):994-1002.
43. Meirelles Lda S, Nardi NB. 2003. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 123(4):702-711.
44. Moren A, Imamura T, Miyazono K, Heldin CH, Moustakas A. 2005. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem 280(23):22115-22123. (Pubitemid 40827867)
45. Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E, Suzuki S, Miyauchi-Hara C, Nagoshi N, Sunabori T, Shimmura S, Miyawaki A, Nakagawa T, Suda T, Okano H, Matsuzaki Y. 2009. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med jem.20091046.
46. Mukherjee S, Raje N, Schoonmaker JA, Liu JC, Hideshima T, Wein MN, Jones DC, Vallet S, Bouxsein ML, Pozzi S, Chhetri S, Seo YD, Aronson JP, Patel C, Fulciniti M, Purton LE, Glimcher LH, Lian JB, Stein G, Anderson KC, Scadden DT. 2008. Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice. J Clin Invest 118(2):491-504.
47. Narimatsu M, Bose R, Pye M, Zhang L, Miller B, Ching P, Sakuma R, Luga V, Roncari L, Attisano L, Wrana JL. 2009. Regulation of planar cell polarity by Smurf ubiquitin ligases. Cell 137(2):295-307.
48. Okada M, Sangadala S, Liu Y, Yoshida M, Reddy BV, Titus L, Boden SD. 2009. Development and optimization of a cell-based assay for the selection of synthetic compounds that potentiate bone morphogenetic protein-2 activity. Cell Biochem Funct 27(8):526-534.
49. Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. 2004. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103(5):1662-1668.
50. Podos SD, Hanson KK, Wang YC, Ferguson EL. 2001. The DSmurf ubiquitin-protein ligase restricts BMP signaling spatially and temporally during Drosophila embryogenesis. Dev Cell 1(4):567-578.
51. Sangadala S, Boden SD, Viggeswarapu M, Liu Y, Titus L. 2006. LIM mineralization protein-1 potentiates bone morphogenetic protein responsiveness via a novel interaction with Smurf1 resulting in decreased ubiquitination of Smads. J Biol Chem 281(25):17212-17219.
52. Sapkota G, Alarcon C, Spagnoli FM, Brivanlou AH, Massague J. 2007. Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol Cell 25(3):441-454.
53. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. 1993. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75(3):495-505.
54. Serra R, Johnson M, Filvaroff EH, LaBorde J, Sheehan DM, Derynck R, Moses HL. 1997. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139(2):541-552. (Pubitemid 27459324)
55. Shembade N, Harhaj NS, Parvatiyar K, Copeland NG, Jenkins NA, Matesic LE, Harhaj EW. 2008. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat Immunol 9(3):254-262. (Pubitemid 351276830)
56. Shen R, Chen M, Wang YJ, Kaneki H, Xing L, O'Keefe RJ, Chen D. 2006a. Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation. J Biol Chem 281(6):3569-3576. (Pubitemid 43845974)
57. Shen R, Wang X, Drissi H, Liu F, O'Keefe RJ, Chen D. 2006b. Cyclin D1-cdk4 induce runx2 ubiquitination and degradation. J Biol Chem 281(24):16347-16353. (Pubitemid 43909583)
58. Shi PP, Cao XR, Sweezer EM, Kinney TS, Williams NR, Husted RF, Nair R, Weiss RM, Williamson RA, Sigmund CD, Snyder PM, Staub O, Stokes JB, Yang B. 2008. Salt-sensitive hypertension and cardiac hypertrophy in mice deficient in the ubiquitin ligase Nedd4-2. Am J Physiol Renal Physiol 295(2):F462-F470.
59. Stroschein SL, Bonni S, Wrana JL, Luo K. 2001. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev 15(21):2822-2836. (Pubitemid 33042053)
60. Swart J, Martens A, Wulffraat N. 2008. Mesenchymal stem cells: a future for the treatment of arthritis? Joint Bone Spine 75(4):379-382.
61. Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. 1998. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95(6):779-791. (Pubitemid 29014458)
62. Varshavsky A. 2003. The N-end rule and regulation of apoptosis. Nat Cell Biol 5(5):373-376.
63. Verdecia MA, Joazeiro CA, Wells NJ, Ferrer JL, Bowman ME, Hunter T, Noel JP. 2003. Conformational flexibility underlies ubiquitin ligation mediated by the WWP1 HECT domain E3 ligase. Mol Cell 11(1):249-259. (Pubitemid 36126605)
64. Viswanathan A, Sylvester FA. 2008. Pediatric inflammatory diseases: effects on bone. Rev Endocr Metab Disord 9(2):107-122.
65. von Mikecz A. 2006. The nuclear ubiquitin-proteasome system. J Cell Sci 119(Pt 10):1977-1984.
66. Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH, Wrana JL. 2003. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 302(5651):1775-1779. (Pubitemid 37505743)
67. Wang Q, Wei X, Zhu T, Zhang M, Shen R, Xing L, O'Keefe RJ, Chen D. 2007. Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2. J Biol Chem 282(14):10742-10748. (Pubitemid 47093462)
68. Whitman M. 1998. Smads and early developmental signaling by the TGFbeta superfamily. Genes Dev 12(16):2445-2462. (Pubitemid 28406948)
69. Wu Q, Kim KO, Sampson ER, Chen D, Awad H, O'Brien T, Puzas JE, Drissi H, Schwarz EM, O'Keefe RJ, Zuscik MJ, Rosier RN. 2008a. Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum 58(10):3132-3144.
70. Wu Q, Chen D, Zuscik MJ, O'Keefe RJ, Rosier RN. 2008b. Overexpression of Smurf2 stimulates endochondral ossification through upregulation of betacatenin. J Bone Miner Res 23:552-563. (Pubitemid 351501896)
71. Wu Q, Huang JH, Sampson ER, Kim KO, Zuscik MJ, O'Keefe RJ, Chen D, Rosier RN. 2009. Smurf2 induces degradation of GSK-3beta and upregulates beta-catenin in chondrocytes: a potential mechanism for Smurf2-induced degeneration of articular cartilage. Exp Cell Res 315:2386-2398.
72. Yamaguchi K, Ohara O, Ando A, Nagase T. 2008. Smurf1 directly targets hPEM-2, a GEF for Cdc42, via a novel combination of protein interaction modules in the ubiquitin-proteasome pathway. Biol Chem 389(4):405-413. (Pubitemid 351773906)
73. Yamashita M, Ying SX, Zhang GM, Li C, Cheng SY, Deng CX, Zhang YE. 2005. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 121(1):101-113. (Pubitemid 40501171)
74. Yang X, Chen L, Xu X, Li C, Huang C, Deng CX. 2001. TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 153(1):35-46. (Pubitemid 34280192)
75. Yang C, Zhou W, Jeon MS, Demydenko D, Harada Y, Zhou H, Liu YC. 2006. Negative regulation of the E3 ubiquitin ligase itch via Fyn-mediated tyrosine phosphorylation. Mol Cell 21(1):135-141. (Pubitemid 43017855)
76. Ying SX, Hussain ZJ, Zhang YE. 2003. Smurf1 facilitates myogenic differentiation and antagonizes the bone morphogenetic protein-2-induced osteoblast conversion by targeting Smad5 for degradation. J Biol Chem 278(40):39029-39036.
77. Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R. 2001. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci USA 98(3):974-979. (Pubitemid 32121172)
78. Zhang Y, Wang HR, Wrana JL. 2004a. Smurf1: a link between cell polarity and ubiquitination. Cell Cycle 3(4):391-392. (Pubitemid 40278217)
79. Zhang X, Srinivasan SV, Lingrel JB. 2004b. WWP1-dependent ubiquitination and degradation of the lung Krüppel-like factor, KLF2. Biochem Biophys Res Commun 316(1):139-148. (Pubitemid 38299138)
80. Zhang M, Xie R, Hou W, Wang B, Shen R, Wang X, Wang Q, Zhu T, Jonason JH, Chen D. 2009. PTHrP prevents chondrocyte premature hypertrophy by inducing cyclin-D1-dependent Runx2 and Runx3 phosphorylation, ubiquitylation and proteasomal degradation. J Cell Sci 122(Pt 9):1382-1389.
81. Zhao M, Qiao M, Oyajobi BO, Mundy GR, Chen D. 2003. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation. J Biol Chem 278(30):27939-27944. (Pubitemid 36899988)
82. Zhao M, Qiao M, Harris SE, Oyajobi BO, Mundy GR, Chen D. 2004. Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo. J Biol Chem 279(13):12854-12859. (Pubitemid 38445859)
83. Zhao L, Huang J, Guo R, Wang L, Chen D, Xing L. 2010. Smurf1 inhibits mesenchymal stem cell proliferation and differentiation into osteoblasts through JunB degradation. J Bone Miner Res [Epub ahead of print].
84. Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH. 1999. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400(6745):687-693. (Pubitemid 129516185)